Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 171

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 171
---
 to satisfy the closing condition in the Merger Agreement that requires NorthView to have a minimum amount of cash at the Closing, however, such purchased shares would not be voted in favor of approving the Business Combination transaction. This may result in the completion of a business combination that may not otherwise have been possible. 73 Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent the purchasers are subject to such reporting requirements. Further, in the event the Sponsor, directors, officers, advisors or any of their respective affiliates were to purchase public shares in privately negotiated transactions from public stockholders, such purchases would be structured in compliance with the requirements of Rule 14e -5under the Exchange Act, including, in relevant part, through adherence to the following: •this proxy statement discloses the possibility that the Sponsor, directors, officers, advisors or any of their respective affiliates may purchase public shares from public stockholders outside the redemption process, along with the purpose of such purchases; •if the Sponsor, directors, officers, advisors or any of their respective affiliates were to purchase public shares from public stockholders: •the Sponsor or such directors, officers, advisors or affiliates would do so at a price no higher than the price offered through our redemption process; •such purchased shares would not be voted in favor of approving the business combination transaction; •the Sponsor or such directors, officers, advisors or affiliates would not possess any redemption rights with respect to such purchased shares or, if they do acquire and possess redemption rights, they would waive such rights; and •we would disclose in a Current Report on Form 8 -K, before the Special Meeting, the following: •the amount of our securities purchased outside of the redemption offer by our Sponsor, directors, officers, advisors or any of their respective affiliates, along with the purchase price; •the purpose of such purchases; •the impact, if any, of such purchases on the likelihood that the Business Combination will be approved; •the identities of our selling stockholders for such purchases (if not purchased on the open market) or the nature of our stockholders (e.g., 5% stockholders) who sold to our Sponsor, directors, officers, advisors or any of their respective affiliates; and •the number of our shares for which we have received redemption requests pursuant to the redemption offer. In addition, if such purchases are made, the public float of NorthView Common Stock and the number of beneficial holders of NorthView’s securities may be reduced, possibly